cefixime and clavulanic acid

cefixime has been researched along with clavulanic acid in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (11.11)	18.7374
1990's	4 (22.22)	18.2507
2000's	7 (38.89)	29.6817
2010's	3 (16.67)	24.3611
2020's	2 (11.11)	2.80

Authors

Authors	Studies
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N	1
Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA	1
Beumer, HM	1
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C	1
Bajaksouzian, S; Jacobs, MR	1
García-Rodríguez, JA	1
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E	1
Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T	1
Ghosh, TK	1
Aggarwal, P; Capoor, MR; Deb, M; Hasan, AS; Nair, D; Pillai, P; Rawat, D; Sarma, S	1
Bingen, E; Biscardi, S; Cohen, R; Epaud, R; Jaby, O; Madhi, F	1
Aberrane, S; Bechet, S; Beraud, L; Bidet, P; Birgy, A; Bonacorsi, S; Cohen, R; Cointe, A; Cuzon, G; Desmarest, M; Dommergues, MA; Ferroni, A; Gajdos, V; Haas, H; Hobson, CA; Jung, C; Launay, E; Levy, C; Madhi, F; Pinquier, D; Sobral, E; Vuthien, H	1
Abu-Raideh, J; Al-Tamimi, M; Albalawi, H; Alhaj, F; Khasawneh, AI; Shalabi, M	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1

Trials

2 trial(s) available for cefixime and clavulanic acid

Article	Year
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". The Journal of pediatrics, 1992, Volume: 120, Issue:1 Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane	1992
Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections. International journal of clinical pharmacology, therapy, and toxicology, 1989, Volume: 27, Issue:1 Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections	1989

Article

Year

Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".

The Journal of pediatrics, 1992, Volume: 120, Issue:1

Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane

1992

Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.

International journal of clinical pharmacology, therapy, and toxicology, 1989, Volume: 27, Issue:1

Topics: Adult; Amoxicillin; Bacterial Infections; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections

1989

Other Studies

16 other study(ies) available for cefixime and clavulanic acid

Article	Year
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:10 Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis	1992
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria. Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:2 Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus	1986
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid. Diagnostic microbiology and infectious disease, 1997, Volume: 28, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins	1997
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results. Chemotherapy, 1998, Volume: 44 Suppl 1 Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections	1998
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae	2001
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae	2006
Cephalosporins with clavulinic acid. Indian pediatrics, 2009, Volume: 46, Issue:1 Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Clavulanic Acid; Drug Therapy, Combination; Humans	2009
In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria. The Southeast Asian journal of tropical medicine and public health, 2009, Volume: 40, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefixime; Clavulanic Acid; Community-Acquired Infections; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2009
Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefixime; Child; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Infant; Microbial Sensitivity Tests; Urinary Tract Infections; Uropathogenic Escherichia coli	2013
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections. The Journal of antimicrobial chemotherapy, 2021, 10-11, Volume: 76, Issue:11 Topics: Amdinocillin; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Child; Clavulanic Acid; Humans; Urinary Tract Infections	2021
Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli. Annals of clinical microbiology and antimicrobials, 2022, May-22, Volume: 21, Issue:1 Topics: Adolescent; Adult; Aged; beta-Lactamases; Cefixime; Cephalosporins; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult	2022
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010